Extended-Spectrum Beta-Lactamase (ESBL) is an enzyme which conveys resistance to most beta-lactam antibiotics. Infections are often difficult to treat due to general multiresistance and hospital care may be necessary even for non-serious infections.
Infection Control Nurse Wiklund’s master’s thesis at NHV is on patients with ESBL-producing bacteria.
“To suffer from an infectious disease can be stressful for the individual, both physically and mentally,” says Susanne Wiklund, whose study deepens the understanding of what it means for individuals to suffer from ESBL-producing intestinal bacteria.
The results show that patients with these bacteria are exposed to an information culture in health care which in some cases is poor, despite legislation.
Read: www.nhv.se/wiklundeng
Order: kirsi.gomes@nhv.se

Press contact:

Louise Teurneau


+46 (0)31 69 39 84

Mobile phone: